Effects of diabetes on the eye

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 14, 2013, Pages

  Lutty, Gerard A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Choroidopathy; Cornea; Diabetes; Inflammation; Retinopathy

Indexed keywords

ACETYLSALICYLIC ACID; CD11 ANTIGEN; CD18 ANTIGEN; ETANERCEPT; INTERCELLULAR ADHESION MOLECULE 1; MELOXICAM; STROMELYSIN 2;

ARTICLE; BLOOD VESSEL PERMEABILITY; CONFOCAL MICROSCOPY; DIABETES MELLITUS; DIABETIC RETINOPATHY; DOWN REGULATION; HUMAN; HYPERGLYCEMIA; KERATOPATHY; LEUKOSTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; UPREGULATION;

EID: 84890318972     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12979     Document Type: Article

References (51)

1. Zhivov A, Winter K, Hovakimyan M, et al. Imaging and quantification of subbasal nerve plexus in healthy volunteers and diabetic patients with or without retinopathy. PLoS One. 2013;8:e52157.
2. He J, Bazan HE. Mapping the nerve architecture of diabetic human corneas. Ophthalmology. 2012;119:956-964.
3. Midena E, Brugin E, Ghirlando A, Sommavilla M, Avogaro A. Corneal diabetic neuropathy: a confocal microscopy study. J Refract Surg. 2006;22:S1047-S1052.
4. Midena E, Cortez M, Miotto S, Gambato C, Cavarzeran F, Ghirlando A. Confocal microscopy of corneal sub-basal nerve plexus: a quantitative and qualitative analysis in healthy and pathologic eyes. J Refract Surg. 2009;25:S125-S130.
5. Chikama T, Wakuta M, Liu Y, Nishida T. Deviated mechanism of wound healing in diabetic corneas. Cornea. 2007;26:S75-S81.
6. Yin J, Huang J, Chen C, Gao N, Wang F, Yu FS. Corneal complications in streptozocin-induced type I diabetic rats. Invest Ophthalmol Vis Sci. 2011;52:6589-6596.
7. Foreman DM, Pancholi S, Jarvis-Evans J, McLeod D, Boulton ME. A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. Exp Eye Res. 1996;62: 555-564.
8. Kabosova A, Kramerov AA, Aoki AM, Murphy G, Zieske JD, Ljubimov AV. Human diabetic corneas preserve wound healing, basement membrane, integrin and MMP-10 differences from normal corneas in organ culture. Exp Eye Res. 2003;77:211-217.
9. Saghizadeh M, Kramerov AA, Yaghoobzadeh Y, et al. Adenovirusdriven overexpression of proteinases in organ-cultured normal human corneas leads to diabetic-like changes. Brain Res Bull. 2010;81:262-272.
10. Saghizadeh M, Kramerov AA, Yu FS, Castro MG, Ljubimov AV. Normalization of wound healing and diabetic markers in organ cultured human diabetic corneas by adenoviral delivery of c-Met gene. Invest Ophthalmol Vis Sci. 2010;51:1970-1980.
11. Adamis AP. Is diabetic retinopathy an inflammatory disease? Br J Ophthalmol. 2002;86:363-365.
12. Kern TS. Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res. 2007;2007:95103.
13. Noda K, Nakao S, Ishida S, Ishibashi T. Leukocyte adhesion molecules in diabetic retinopathy. J Ophthalmol. 2012;2012: 279037.
14. Clausell N, Kalil P, Biolo A, Molossi S, Azevedo M. Increased expression of tumor necrosis factor-alpha in diabetic macrovasculopathy. Cardiovasc Pathol. 1999;8:145-151.
15. Clausen P, Jacobsen P, Rossing K, Jensen JS, Parving HH, Feldt-Rasmussen B. Plasma concentrations of VCAM-1 and ICAM-1 are elevated in patients with Type 1 diabetes mellitus with microalbinuria and overt nephropathy. Diabet Med. 2000;17: 644-649.
16. Wierusz-Wysocki B, Wysocki H, Siekierka H, Wykretowicz A, Szcaepanik A, Klimas R. Evidence of polymorphonuclear neutrophils (PMN) activation in patients with insulin-dependent diabetes mellitus. J Leukoc Biol. 1987;42:519-523.
17. Nishiwaki H, Ogura Y, Kimura H, Kiryu J, Honda Y. Quantitative evaluation of leukocyte dynamics in retinal microcirculation. Invest Ophthalmol Vis Sci. 1995;36:123-130.
18. Joussen AM, Murata T, Tsujikawa A, Kirchhof B, Bursell S-E, Adamis AP. Leukocyte-mediated endothelial cell injury and death in the diabetic retina. Am J Pathol. 2001;158:147-152.
19. Joussen AM, Poulaki V, Mitsiades N, et al. Nonsteroidal antiinflammatory drugs prevent early diabetic retinopathy via TNF-a suppression. FASEB J. 2002;16:438-440.
20. Joussen AM, Poulaki V, Le ML, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18:1450-1452.
21. Hughes JM. Leukostasis and inflammation: crucial steps in the development of diabetic retinopathy or epiphenomenon. In: Hughes JM, ed. Endothelial Dysfunction in Experimental Models of Preclinical Diabetic Retinopathy. Amsterdam: Academic Medical Center-University of Amsterdam; 2010.
22. Grunwald JE, Bursell S-E. Hemodynamic changes as early markers of diabetic retinopathy. Curr Opin Endocrinol Diabetes. 1996;3:298-306.
23. Abiko T, Abiko A, Clermont AC, et al. Characterization of retinal leukostasis and hemodynamics in insulin resistance and diabetes: role of oxidants and protein kinase-C activation. Diabetes. 2003;52:829-837.
24. Miyamoto K, Hiroshiba N, Tsujikawa A, Ogura Y. In vivo demonstration of increased leukocyte entrapment in retinal microcirculation of diabetic rats. Invest Ophthalmol Vis Sci. 1998;39:2190-2194.
25. Chakravarthy U, Hayes RG, Stitt AW, Douglas A. Endothelin expression in ocular tissues of diabetic and insulin-treated rats. Invest Ophthalmol Vis Sci. 1997;38:2144-2151.
26. Takagi C, King GL, Takagi H, Lin YW, Clermont AC, Bursell SE. Endothelin-1 action via endothelin receptors is a primary mechanism modulating retinal circulatory response to hyperoxia. Invest Ophthalmol Vis Sci. 1996;37:2099-2109.
27. Braun R, Fisher T, Meiselman H, Hatchell D. Decreased deformability of polynuclear leukocytes in diabetic cats. Microcirculation. 1996;3:271-278.
28. Schmid-Schönbein GW. Granulocyte activation and capillary obstruction. Monogr Atheroscler. 1990;15:150-159.
29. Lutty GA, McLeod DS. Phosphatase enzyme histochemistry for studying vascular hierarchy, pathology, and endothelial cell dysfunction in retina and choroid. Vision Res. 2005;45:3504-3511.
30. Kim SY, Johnson MA, McLeod DS, Alexander T, Hansen BC, Lutty GA. Neutrophils are associated with capillary closure in spontaneously diabetic monkey retinas. Diabetes. 2005;54: 1534-1542.
31. Lu ZY, Bhutto IA, Amemiya T. Retinal changes in Otsuka longevans Tokushima fatty rats (spontaneously diabetic rat)-possibility of a new experimental model for diabetic retinopathy. Jpn J Ophthalmol. 2003;47:28-35.
32. McLeod DS, Lefer DJ, Merges C, Lutty GA. Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid. Am J Pathol. 1995;147: 642-653.
33. Nozaki M, Ogura Y, Hirabayashi Y, Saishin Y, Shimada S. Enhanced expression of adhesion molecules of the retinal vascular endothelium in spontaneous diabetic rats. Ophthalmic Res. 2002;34:158-164.
34. Miyamoto K, Khosrof S, Bursell SE, et al. Prevention of leukostasis and vascular leakage in streptozotocin-induced diabetic retinopathy via intercellular adhesion molecule-1 inhibition. Proc Natl Acad Sci U S A. 1999;96:10836-10841.
35. Barouch F, Miyamoto K, Allport J, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci. 2000;41:1153-1158.
36. Kohner EM, Henkind P. Correlation of fluorescein angiogram and retinal digest in diabetic retinopathy. Am J Ophthalmol. 1970;69:403-414.
37. Tolentino MJ, Husain D, Theodosiadis P, et al. Angiography of fluorestricted anti-vascular endothelial growth factor antibody and dextrans in experimental choroidal neovascularization. Arch Ophthalmol. 2000;118:78-84.
38. Tolentino MJ, McLeod DS, Taomoto M, Otsuji T, Adamis AP, Lutty GA. Pathological features of vascular endothelial growth factorinduced retinopathy in non-human primates. Am J Ophthalmol. 2002;133:373-385.
39. Lu M, Perez V, Ma N, et al. VEGF increases retinal ICAM-1 expression in vivo. Invest Ophthalmol Vis Sci. 1999;40:1808-1812.
40. D'Amore PA. Mechanisms of retinal and choroidal neovascularization. Invest Ophthalmol Vis Sci. 1994;35:3974-3979.
41. Lutty GA, McLeod DS. A new technique for visualization of the human retinal vasculature. Arch Ophthalmol. 1992;110:267-276.
42. Cao J, McLeod S, Merges CA, Lutty GA. Choriocapillaris degeneration and related pathologic changes in human diabetic eyes. Arch Ophthalmol. 1998;116:589-597.
43. Lutty GA, Cao J, McLeod DS. Relationship of polymorphonuclear leukocytes (PMNs) to capillary dropout in the human diabetic choroid. Am J Pathol. 1997;151:707-714.
44. Fukushima I, McLeod DS, Lutty GA. Intrachoroidal microvascular abnormality, a previously unrecognized form of choroidal neovascularization. Am J Ophthalmol. 1997;124:473-487.
45. McLeod DS, Lutty GA. High resolution histologic analysis of the human choroidal vasculature. Invest Ophthalmol Vis Sci. 1994; 35:3799-3811.
46. Jarajapu YP, Caballero S, Verma A, et al. Blockade of NADPH oxidase restores vasoreparative function in diabetic CD34{thorn} cells. Invest Ophthalmol Vis Sci. 2011;52:5093-5104.
47. Shaw LC, Neu MB, Grant MB. Cell-based therapies for diabetic retinopathy. Curr Diab Rep. 2011;11:265-274.
48. Caballero S, Sengupta N, Afzal A, et al. Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells. Diabetes. 2007;56:960-967.
49. Segal MS, Shah R, Afzal A, et al. Nitric oxide cytoskeletal-induced alterations reverse the endothelial progenitor cell migratory defect associated with diabetes. Diabetes. 2006;55:102-109.
50. Park TS, Huo JS, Peters A, et al. Growth factor-activated stem cell circuits and stromal signals cooperatively accelerate nonintegrated iPSC reprogramming of human myeloid progenitors. PLoS One. 2012;7:e42838.
51. Park TS, Zimmerlin L, Zambidis ET. Efficient and simultaneous generation of hematopoietic and vascular progenitors from human induced pluripotent stem cells. Cytometry A. 2013;83: 114-126.